JTC Employer Solutions Trustee’s Corbus Pharmaceuticals CRBP Stock Holding History

JTC Employer Solutions Trustee’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10K	Hold	1,106	–	–	﹤0.01%	285
2026 Q1	$10K	Hold	1,106	–	–	﹤0.01%	279
2025 Q4	$9K	Hold	1,106	–	–	﹤0.01%	283
2025 Q3	$14K	Hold	1,106	–	–	﹤0.01%	280
2025 Q2	$8K	Hold	1,106	–	–	﹤0.01%	278
2025 Q1	$6K	Hold	1,106	–	–	﹤0.01%	292
2024 Q4	$13K	Hold	1,106	–	–	﹤0.01%	283
2024 Q3	$23K	Hold	1,106	–	–	﹤0.01%	275
2024 Q2	$50K	Hold	1,106	–	–	﹤0.01%	247
2024 Q1	$39K	Hold	1,106	–	–	﹤0.01%	266
2023 Q4	$7K	Hold	1,106	–	–	﹤0.01%	318
2023 Q3	$7K	Hold	1,106	–	–	﹤0.01%	324
2023 Q2	$9K	Hold	1,106	–	–	﹤0.01%	326
2023 Q1	$8K	Hold	1,106	–	–	﹤0.01%	337
2022 Q4	$4K	Hold	1,106	–	–	﹤0.01%	371
2022 Q3	$6K	Hold	1,106	–	–	﹤0.01%	296
2022 Q2	$8K	Hold	1,106	–	–	﹤0.01%	268
2022 Q1	$18K	Hold	1,106	–	–	﹤0.01%	252
2021 Q4	$20K	Hold	1,106	–	–	﹤0.01%	249
2021 Q3	$34K	Hold	1,106	–	–	﹤0.01%	235
2021 Q2	$61K	Buy	+1,106	New	+$61.4K	0.01%	198

Other funds holding CRBP

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

JTC Employer Solutions Trustee's CRBP Position: Q2 2026 in Review

JTC Employer Solutions Trustee held its Corbus Pharmaceuticals (CRBP) position steady in Q2 2026 at 1,106 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #285.

JTC Employer Solutions Trustee first reported a position in CRBP in Q2 2021 and has held it in 21 quarters since. The position peaked at $61K in Q2 2021. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

JTC Employer Solutions Trustee held 1,106 shares of Corbus Pharmaceuticals worth $10K as of Q2 2026.
JTC Employer Solutions Trustee left its Corbus Pharmaceuticals share count unchanged in Q2 2026.
Corbus Pharmaceuticals made up ﹤0.01% of JTC Employer Solutions Trustee's portfolio in Q2 2026, its #285 holding.
JTC Employer Solutions Trustee first reported a position in Corbus Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
JTC Employer Solutions Trustee's Corbus Pharmaceuticals position peaked at $61K in Q2 2021.
107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q2 2026, filed 31 Jul 2026.